Annual accounts receivable:
$9.40B+$99.00M(+1.06%)Summary
- As of today (August 26, 2025), BMY annual accounts receivable is $9.40 billion, with the most recent change of +$99.00 million (+1.06%) on December 31, 2024.
- During the last 3 years, BMY annual accounts receivable has risen by +$1.06 billion (+12.67%).
- BMY annual accounts receivable is now at all-time high.
Performance
BMY Accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly accounts receivable:
$9.96B+$573.00M(+6.10%)Summary
- As of today (August 26, 2025), BMY quarterly accounts receivable is $9.96 billion, with the most recent change of +$573.00 million (+6.10%) on June 30, 2025.
- Over the past year, BMY quarterly accounts receivable has dropped by -$173.00 million (-1.71%).
- BMY quarterly accounts receivable is now -1.71% below its all-time high of $10.13 billion, reached on June 30, 2024.
Performance
BMY Quarterly accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
BMY Accounts receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1.1% | -1.7% |
| 3 y3 years | +12.7% | +24.4% |
| 5 y5 years | +45.1% | +48.7% |
BMY Accounts receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +12.7% | -1.7% | +24.4% |
| 5 y | 5-year | at high | +45.1% | -1.7% | +48.7% |
| alltime | all time | at high | +429.1% | -1.7% | +317.4% |
BMY Accounts receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $9.96B(+6.1%) |
| Mar 2025 | - | $9.39B(-0.1%) |
| Dec 2024 | $9.40B(+1.1%) | $9.40B(-3.2%) |
| Sep 2024 | - | $9.71B(-4.2%) |
| Jun 2024 | - | $10.13B(+9.7%) |
| Mar 2024 | - | $9.23B(-0.7%) |
| Dec 2023 | $9.30B(+7.4%) | $9.30B(+5.5%) |
| Sep 2023 | - | $8.82B(+3.4%) |
| Jun 2023 | - | $8.53B(+2.0%) |
| Mar 2023 | - | $8.36B(-3.4%) |
| Dec 2022 | $8.65B(+3.8%) | $8.65B(+2.2%) |
| Sep 2022 | - | $8.47B(+5.8%) |
| Jun 2022 | - | $8.01B(+5.8%) |
| Mar 2022 | - | $7.57B(-9.3%) |
| Dec 2021 | $8.34B(+15.5%) | $8.34B(+5.9%) |
| Sep 2021 | - | $7.88B(+2.1%) |
| Jun 2021 | - | $7.71B(+7.3%) |
| Mar 2021 | - | $7.19B(-0.4%) |
| Dec 2020 | $7.22B(+11.5%) | $7.22B(+6.5%) |
| Sep 2020 | - | $6.78B(+1.2%) |
| Jun 2020 | - | $6.70B(-7.0%) |
| Mar 2020 | - | $7.20B(+11.2%) |
| Dec 2019 | $6.48B(+27.8%) | $6.48B(+51.0%) |
| Sep 2019 | - | $4.29B(-4.8%) |
| Jun 2019 | - | $4.50B(-3.1%) |
| Mar 2019 | - | $4.64B(-8.3%) |
| Dec 2018 | $5.07B(+8.5%) | $5.07B(+5.2%) |
| Sep 2018 | - | $4.82B(+11.4%) |
| Jun 2018 | - | $4.32B(-1.2%) |
| Mar 2018 | - | $4.37B(-6.3%) |
| Dec 2017 | $4.67B(-0.2%) | $4.67B(-10.4%) |
| Sep 2017 | - | $5.21B(+2.3%) |
| Jun 2017 | - | $5.09B(+2.3%) |
| Mar 2017 | - | $4.98B(+6.5%) |
| Dec 2016 | $4.68B(+19.7%) | $4.68B(-4.5%) |
| Sep 2016 | - | $4.90B(+0.5%) |
| Jun 2016 | - | $4.87B(+8.8%) |
| Mar 2016 | - | $4.48B(+14.6%) |
| Dec 2015 | $3.91B(+30.7%) | $3.91B(+10.0%) |
| Sep 2015 | - | $3.55B(+5.5%) |
| Jun 2015 | - | $3.37B(+5.1%) |
| Mar 2015 | - | $3.21B(+7.3%) |
| Dec 2014 | $2.99B(+6.3%) | $2.99B(+3.6%) |
| Sep 2014 | - | $2.88B(+1.8%) |
| Jun 2014 | - | $2.83B(-0.2%) |
| Mar 2014 | - | $2.84B(+0.9%) |
| Dec 2013 | $2.81B | $2.81B(-8.8%) |
| Sep 2013 | - | $3.08B(+7.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2013 | - | $2.87B(+3.6%) |
| Mar 2013 | - | $2.77B(+7.9%) |
| Dec 2012 | $2.56B(-23.0%) | $2.56B(+3.1%) |
| Sep 2012 | - | $2.49B(-0.3%) |
| Jun 2012 | - | $2.50B(-21.8%) |
| Mar 2012 | - | $3.19B(-4.2%) |
| Dec 2011 | $3.33B(+8.8%) | $3.33B(+2.3%) |
| Sep 2011 | - | $3.26B(-5.1%) |
| Jun 2011 | - | $3.43B(+7.7%) |
| Mar 2011 | - | $3.19B(+4.1%) |
| Dec 2010 | $3.06B(+10.6%) | $3.06B(+7.6%) |
| Sep 2010 | - | $2.85B(+3.3%) |
| Jun 2010 | - | $2.75B(-8.6%) |
| Mar 2010 | - | $3.01B(+8.9%) |
| Dec 2009 | $2.77B(-19.0%) | $2.77B(-17.6%) |
| Sep 2009 | - | $3.36B(+4.4%) |
| Jun 2009 | - | $3.21B(+1.7%) |
| Mar 2009 | - | $3.16B(-7.5%) |
| Dec 2008 | $3.42B(-1.0%) | $3.42B(-13.7%) |
| Sep 2008 | - | $3.96B(+5.2%) |
| Jun 2008 | - | $3.76B(+1.3%) |
| Mar 2008 | - | $3.72B(+7.7%) |
| Dec 2007 | $3.45B(+43.7%) | $3.45B(+3.6%) |
| Sep 2007 | - | $3.33B(+0.7%) |
| Jun 2007 | - | $3.31B(+7.8%) |
| Mar 2007 | - | $3.06B(+27.7%) |
| Dec 2006 | $2.40B(-7.3%) | $2.40B(-7.3%) |
| Dec 2005 | $2.59B(-22.7%) | $2.59B(-7.7%) |
| Dec 2004 | $3.35B(+11.3%) | - |
| Dec 2003 | $3.01B(+12.8%) | - |
| Dec 2002 | $2.67B(-21.0%) | - |
| Dec 2001 | $3.38B(-7.7%) | - |
| Dec 2000 | $3.66B(+11.9%) | - |
| Dec 1999 | $3.27B(+2.6%) | - |
| Dec 1998 | $3.19B(+7.3%) | - |
| Dec 1997 | $2.97B(+12.1%) | - |
| Sep 1997 | - | $2.81B(+1.1%) |
| Jun 1997 | - | $2.77B(+2.2%) |
| Mar 1997 | - | $2.71B(+10.8%) |
| Dec 1996 | $2.65B(+12.5%) | - |
| Sep 1996 | - | $2.45B(-0.7%) |
| Jun 1996 | - | $2.47B(+3.4%) |
| Mar 1996 | - | $2.39B |
| Dec 1995 | $2.36B(+15.3%) | - |
| Dec 1994 | $2.04B(+9.9%) | - |
| Dec 1993 | $1.86B(-6.3%) | - |
| Dec 1992 | $1.98B(+0.7%) | - |
| Dec 1991 | $1.97B(+11.0%) | - |
| Dec 1990 | $1.78B | - |
FAQ
- What is Bristol-Myers Squibb Company annual accounts receivable?
- What is the all time high annual accounts receivable for Bristol-Myers Squibb Company?
- What is Bristol-Myers Squibb Company annual accounts receivable year-on-year change?
- What is Bristol-Myers Squibb Company quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Bristol-Myers Squibb Company?
- What is Bristol-Myers Squibb Company quarterly accounts receivable year-on-year change?
What is Bristol-Myers Squibb Company annual accounts receivable?
The current annual accounts receivable of BMY is $9.40B
What is the all time high annual accounts receivable for Bristol-Myers Squibb Company?
Bristol-Myers Squibb Company all-time high annual accounts receivable is $9.40B
What is Bristol-Myers Squibb Company annual accounts receivable year-on-year change?
Over the past year, BMY annual accounts receivable has changed by +$99.00M (+1.06%)
What is Bristol-Myers Squibb Company quarterly accounts receivable?
The current quarterly accounts receivable of BMY is $9.96B
What is the all time high quarterly accounts receivable for Bristol-Myers Squibb Company?
Bristol-Myers Squibb Company all-time high quarterly accounts receivable is $10.13B
What is Bristol-Myers Squibb Company quarterly accounts receivable year-on-year change?
Over the past year, BMY quarterly accounts receivable has changed by -$173.00M (-1.71%)